4-Ethynyl-N,N-dimethylaniline

CAS: 17573-94-3

Ref. 3D-SAA57394

Product Information

• Name: 4-Ethynyl-N,N-dimethylaniline
• Synonyms: (4-Ethynyl-Phenyl)-Dimethyl-Amine, (4-Ethynylphenyl)dimethylamine, 1-(Dimethylamino)-4-ethynylbenzene, 1-Ethynyl-4-(dimethylamino)benzene, 1-Ethynyl-4-Dimethylaniline, 4-(Dimethylamino)phenylethyne, 4-Dimethylaminophenylacetylene, 4-Ethynyl-N,N-Dimethylaniline, 4-Ethynyl-N,N-Dimethylbenzenamine, 4-Ethynyl-N,N-dimethylaminobenzene, 4-Ethynylphenyl-N,N-dimethylamine, 4-Phenylthiomorpholine 1,1-Dioxide, Aniline, p-ethynyl-N,N-dimethyl-, Benzenamine, 4-Ethynyl-N,N-Dimethyl-, N,N-Dimethyl-4-Ethynylbenezeamine, N,N-Dimethyl-4-ethynylaniline, N,N-Methyl-4-ethynylaniline, N-(4-Ethynylphenyl)-N,N-dimethylamine, [4-(N,N-Dimethylamino)phenyl]acetylene, [p-(Dimethylamino)phenyl]acetylene, p-(N,N-Dimethylamino)phenylacetylene, p-Ethynyl-N,N-dimethylaniline

Description

4-Ethynyl-N,N-dimethylaniline (EDMA) is a potential drug candidate for the treatment of cancer. EDMA has been shown to have anti-cancer activity in vitro and in vivo. It inhibits the growth of cancer cells by binding to amines and other functional groups, which prevents their use by enzymes. This binding also prevents the production of reactive oxygen species, leading to cell death. The structure of EDMA has been determined using X-ray crystallography, which showed that it binds to chloride ions in a catalytic mechanism. The chloride ion was found to be an important component for the drug’s activity. EDMA also has anti-inflammatory properties due to its ability to inhibit hydroxamic acid synthesis in neutrophils and macrophages.

The following are descriptions for six products:

1) 6-Fluoro-3-indoxyl-beta-D-galactopyranoside

• Brand: Biosynth

Chemical properties

• Molecular weight: 145.2 g/mol
• Formula: C₁₀H₁₁N
• Purity: Min. 95%